The Effect of Intravenous Vitamin C on Cancer- and Chemotherapy-related Fatigue and Quality of Life

Overview

Journal Front Oncol

Specialty Oncology

Date 2014 Nov 1

PMID 25360419

Citations 46

Authors

Anitra C Carr

Margreet C M Vissers

John S Cook

Affiliations

Soon will be listed here.

Abstract

Cancer patients commonly experience a number of symptoms of disease progression and the side-effects of radiation therapy and adjuvant chemotherapy, which adversely impact on their quality of life (QOL). Fatigue is one of the most common and debilitating symptom reported by cancer patients and can affect QOL more than pain. Several recent studies have indicated that intravenous (IV) vitamin C alleviates a number of cancer- and chemotherapy-related symptoms, such as fatigue, insomnia, loss of appetite, nausea, and pain. Improvements in physical, role, cognitive, emotional, and social functioning, as well as an improvement in overall health, were also observed. In this mini review, we briefly cover the methods commonly used to assess health-related QOL in cancer patients, and describe the few recent studies examining the effects of IV vitamin C on cancer- and chemotherapy-related QOL. We discuss potential mechanisms that might explain an improvement in QOL and also considerations for future studies.

Citing Articles

Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy.

Isola S, Gammeri L, Furci F, Gangemi S, Pioggia G, Allegra A Int J Mol Sci. 2024; 25(13).

PMID: 39000393 PMC: 11241675. DOI: 10.3390/ijms25137284.

Preoperative and postoperative administration of vitamin C in cardiac surgery patients - settings, dosages, duration, and clinical outcomes: a narrative review.

Athanasiou A, Charalambous M, Anastasiou T, Aggeli K, Soteriades E Ann Med Surg (Lond). 2024; 86(6):3591-3607.

PMID: 38846824 PMC: 11152825. DOI: 10.1097/MS9.0000000000002112.

Smith K, Hoogland A, Welniak T, Nguyen O, Rodriguez Y, Li X Support Care Cancer. 2024; 32(3):184.

PMID: 38393418 PMC: 11273955. DOI: 10.1007/s00520-024-08385-7.

Scurvy: A treatable forgotten fatal differential diagnosis and potential etiology of leukemia and aplastic anemia in pediatric population.

Mashauri H Health Sci Rep. 2023; 6(10):e1611.

PMID: 37808934 PMC: 10552072. DOI: 10.1002/hsr2.1611.

Vitamin C deficiency in patients with acute myeloid leukemia: a case series and review of the literature.

Milbar H, Caplan A, Schwab R, Coromilas A, Baumrin E, Forrestel A Blood Adv. 2023; 7(19):5780-5783.

PMID: 37433638 PMC: 10560999. DOI: 10.1182/bloodadvances.2023009923.

References

Mikirova N, Casciari J, Rogers A, Taylor P . Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med. 2012; 10:189. PMC: 3480897. DOI: 10.1186/1479-5876-10-189. View

Cocks K, King M, Velikova G, de Castro Jr G, Martyn St-James M, Fayers P . Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer. 2012; 48(11):1713-21. DOI: 10.1016/j.ejca.2012.02.059. View

Rebouche C . Ascorbic acid and carnitine biosynthesis. Am J Clin Nutr. 1991; 54(6 Suppl):1147S-1152S. DOI: 10.1093/ajcn/54.6.1147s. View

Ruddy K, Barton D, Loprinzi C . Laying to rest psychostimulants for cancer-related fatigue?. J Clin Oncol. 2014; 32(18):1865-7. DOI: 10.1200/JCO.2014.55.8353. View

Carr A, Vissers M, Cook J . Relief from cancer chemotherapy side effects with pharmacologic vitamin C. N Z Med J. 2014; 127(1388):66-70. View

Monti D, Mitchell E, Bazzan A, Littman S, Zabrecky G, Yeo C . Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One. 2012; 7(1):e29794. PMC: 3260161. DOI: 10.1371/journal.pone.0029794. View

Wilson M, Baguley B, Wall C, Jameson M, Findlay M . Review of high-dose intravenous vitamin C as an anticancer agent. Asia Pac J Clin Oncol. 2014; 10(1):22-37. DOI: 10.1111/ajco.12173. View

Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q . High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014; 6(222):222ra18. DOI: 10.1126/scitranslmed.3007154. View

Hrobjartsson A, Gotzsche P . Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010; (1):CD003974. PMC: 7156905. DOI: 10.1002/14651858.CD003974.pub3. View

10.

ENGLARD S, SEIFTER S . The biochemical functions of ascorbic acid. Annu Rev Nutr. 1986; 6:365-406. DOI: 10.1146/annurev.nu.06.070186.002053. View

11.

Seely D, Stempak D, Baruchel S . A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology. J Pediatr Hematol Oncol. 2007; 29(1):32-47. DOI: 10.1097/MPH.0b013e3180310521. View

12.

Stein K, Martin S, Hann D, Jacobsen P . A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998; 6(3):143-52. DOI: 10.1046/j.1523-5394.1998.006003143.x. View

13.

Hoffer L, Levine M, Assouline S, Melnychuk D, Padayatty S, Rosadiuk K . Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol. 2008; 19(11):1969-74. DOI: 10.1093/annonc/mdn377. View

14.

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

15.

Dachs G, Munn D, Carr A, Vissers M, Robinson B . Consumption of vitamin C is below recommended daily intake in many cancer patients and healthy volunteers in Christchurch. N Z Med J. 2014; 127(1390):73-6. View

16.

Carr A, Frei B . Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999; 69(6):1086-107. DOI: 10.1093/ajcn/69.6.1086. View

17.

Padayatty S, Sun A, Chen Q, Espey M, Drisko J, Levine M . Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010; 5(7):e11414. PMC: 2898816. DOI: 10.1371/journal.pone.0011414. View

18.

Reuter S, Gupta S, Chaturvedi M, Aggarwal B . Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010; 49(11):1603-16. PMC: 2990475. DOI: 10.1016/j.freeradbiomed.2010.09.006. View

19.

Mayland C, Bennett M, Allan K . Vitamin C deficiency in cancer patients. Palliat Med. 2005; 19(1):17-20. DOI: 10.1191/0269216305pm970oa. View

20.

Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J . Intravenous Vitamin C and Cancer: A Systematic Review. Integr Cancer Ther. 2014; 13(4):280-300. DOI: 10.1177/1534735414534463. View